Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study

BACKGROUND: Since direct-acting antivirals (DAAs) have been approved for the treatment of hepatitis C virus (HCV) infection, a small series of patients with new-onset neuropsychiatric alterations have been referred to us. We therefore set out to study neuropsychiatric function in relation to DAAs pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpato, Sofia, Montagnese, Sara, Zanetto, Alberto, Turco, Matteo, De Rui, Michele, Ferrarese, Alberto, Amodio, Piero, Germani, Giacomo, Senzolo, Marco, Gambato, Martina, Russo, Francesco Paolo, Burra, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759705/
https://www.ncbi.nlm.nih.gov/pubmed/29333276
http://dx.doi.org/10.1136/bmjgast-2017-000183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759705/
https://www.ncbi.nlm.nih.gov/pubmed/29333276
http://dx.doi.org/10.1136/bmjgast-2017-000183

Ejemplares similares